Biotech China 2014

View Profile


Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors
1. 2011 Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia Glycobiology , 21(2):195-205
2. 2011 Common aberrations from the normal human plasma N-glycan profile Glycobiology. 20(8): 970-5.
3. 2011 The N-glycosylation of classical swine fever virus E2 glycoprotein extracellular domain expressed in the milk of goat Arch Biochem Biophys. 500(2): 169-80
4. 2011 Platform technology to identify potential disease markers and establish heritability and environmental determinants of the human serum N-glycome Carbohydr Res. 345(10): 1280-2
5. 2011 Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans Glycobiology. 20(8): 959-69
6. 2011 Identification of by-products formed during the release of N-glycans with protein N-glycosidase F in the presence of dithiothreitol J Mass Spectrom. 45(7): 815-9
7. 2011 Chemical and enzymatic N-glycan release comparison for N-glycan profiling of monoclonal antibodies expressed in plants Anal Biochem. 400(2): 173-83
8. 2011 Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia J Proteome Res
9. 2010 High-throughput glycoanalytical technology for systems glycobiology . Biochem Soc Trans. 38(5):1374-1377
10. 2010 Effect of sialic acid content on glycoprotein pI analyzed by two-dimensional electrophoresis Electrophoresis. 31, 2903-2912
11. 2010 Levels of Specific Glycans Significantly Distinguish Lymph Node-Positive from Lymph Node-Negative Breast Cancer Patients Glycobiology. 2010 Oct;20(10):1283-8. Epub 2010 Jun 24.
12. 2010 Fragmentation of negative ions from N-linked carbohydrates, part 4. Fragmentation of complex glycans lacking substitution on the 6-antenna J Mass Spectrom. 45(5): 528-35
13. 2010 Identification of N-linked carbohydrates from severe acute respiratory syndrome (SARS) spike glycoprotein Virology. 399(2): 257-69
14. 2010 GlycoExtractor: a web-based interface for high throughput processing of HPLC-glycan data J Proteome Res. 9(4): 2037-41
15. 2010 Identification of N-glycans from Ebola virus glycoproteins by matrix-assisted laser desorption/ionisation time-of-flight and negative ion electrospray tandem mass spectrometry Rapid Commun Mass Spectrom. 24(5): 571-85.
16. 2010 Galactosemia, a single gene disorder with epigenetic consequences Pediatr Res. 67(3): 286-92
17. 2010 Activation state and intracellular trafficking contribute to the repertoire of endogenous glycosphingolipids presented by CD1d Proc Natl Acad Sci U S A. 107(7): 3052-7
18. 2010 Separation of 2-aminobenzamide labeled glycans using hydrophilic interaction chromatography columns packed with 1.7 microm sorbent J Chromatogr B Analyt Technol Biomed Life Sci. 878(3-4): 403-8
19. 2010 Complex genetic regulation of protein glycosylation. Mol Biosyst. 6(2): 329-35.
20. 2010 Glycosylation of Therapeutic IgGs Therapeutic Monoclonal Antibodies: From Bench to Clinic, Z. An, Editor, Wiley-Blackwell. 67-89
21. 2010 Liver proteins as sensor of human malignancies and inflammation Proteomics Clin Appl 4(4):426-431
22. 2010 Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1alpha as a master regulator of plasma protein fucosylation PLoS Genetics 6(12):e1001256
23. 2010 Ultra performance liquid chromatographic profiling of serum N-glycans for fast and efficient identification of cancer associated alterations in glycosylation Anal Chem, 82(24):10208-10215.
24. 2010 Glycosylation of liver acute-phase proteins in pancreatic cancer and chronic pancreatitis. Proteomics Clin Appl , 4(4):432-448
25. 2010 Glycan Characterization of PSA 2-DE Subforms from Serum and Seminal Plasma OMICS, 14(4):465-474
26. 2010 The N-glycosylation of classical swine fever virus E2 glycoprotein extracellular domain expressed in the milk of goat Arch Biochem Biophys, 500(2):169-180
27. 2010 Differential modulation of angiogenesis by erythropoiesis-stimulating agents in a mouse model of ischaemic retinopathy Plos One, 5(7):e11870-11871 - e11870-11816
28. 2010 A systematic approach to protein glycosylation analysis: a path through the maze Nat Chem Biol, 6(10):713-723
29. 2009 Identification of high-mannose and multiantennary complex-type N-linked glycans containing alpha-galactose epitopes from Nurse shark IgM heavy chain Glycoconj J. 26(8): 1055-64.
30. 2009 Soluble CD36 ectodomain binds negatively charged diacylglycerol ligands and acts as a co-receptor for TLR2 PLoS One. 4(10): e7411
31. 2009 Proposal for a standard system for drawing structural diagrams of N- and O-linked carbohydrates and related compounds. Proteomics. 9(15): 3796-801
32. 2009 Detailed N-glycan analysis of mannose receptor purified from murine spleen indicates tissue specific sialylation Biochem Biophys Res Commun. 384(4): 436-43.
33. 2009 The conformational properties of the Glc3Man unit suggest conformational biasing within the chaperone-assisted glycoprotein folding pathway J Mol Biol. 387(2): 335-47
34. 2009 High-throughput glycome analysis is set to join high-throughput genomics J Proteome Res. 8(3): 1105
35. 2009 Variability, heritability and environmental determinants of human plasma N-glycome J Proteome Res. 8(2): 694-701
36. 2009 N-glycosylation pattern of E2 glycoprotein from classical swine fever virus. J Proteome Res. 8(2): 546-55
37. 2009 The second golden age of glycomics: from functional glycomics to clinical applications J Proteome Res. 8(2): 425-6
38. 2009 Glycosylation changes on serum glycoproteins in ovarian cancer may contribute to disease pathogenesis Dis Markers. 25(4-5): 219-32
39. 2008 Remarkable selective glycosylation of the immunoglobulin variable region in follicular lymphoma. Mol Immunol. 45(6): 1567-72
40. 2008 Altered glycosylation in tumours focused to cancer diagnosis. Dis Markers. 25(4-5): 207-18.
41. 2008 Disease related glycosylation changes and biomarker discovery: challenges and possibilities in an emerging field. Editorial. Dis Markers. 25(4-5): 189-92
42. 2008 GlycoScience Ireland initiative Journal of Proteome Research. 7(7): 2585-2585
43. 2008 Glycobiology - discovery, diagnostics and drugs Glycobiology, C. Sansom, Markman, O., Editor, Scion Publishing Ltd. 8-11
44. 2008 Altered glycosylation in tumours focused to cancer diagnosis Dis Markers. 25(4-5): 207-18
45. 2008 Disease related glycosylation changes and biomarker discovery: challenges and possibilities in an emerging field Dis Markers. 25(4-5): 189-92
46. 2008 A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression Glycobiology. 18(12): 1105-18
47. 2008 Glycan structures of ocular surface mucins in man, rabbit and dog display species differences Glycoconj J. 25(8): 763-73.
48. 2008 Plant N-glycan profiling of minute amounts of material Anal Biochem. 379(1): 66-72
49. 2008 Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation Proteomics. 8(16): 3284-93.
50. 2008 GlycoScience Ireland initiative Journal of Proteome Research. 7(7): 2585-2585
51. 2008 Genes contributing to prion pathogenesis. J Gen Virol. 89(Pt 7): 1777-88
52. 2008 The O-linked glycosylation of secretory/shed MUC1 from an advanced breast cancer patient's serum Glycobiology. 18(6): 456-62
53. 2008 Structural and quantitative analysis of N-linked glycans by matrix-assisted laser desorption ionization and negative ion nanospray mass spectrometry Anal Biochem. 376(1): 44-60
54. 2008 Frontiers in glycomics: bioinformatics and biomarkers in disease. An NIH white paper prepared from discussions by the focus groups at a workshop on the NIH campus, Bethesda MD (September 11-13, 2006). Proteomics. 8(1): 8-20
55. 2008 HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. Anal Biochem. 376(1): 1-12
56. 2008 GlycoBase and autoGU: tools for HPLC-based glycan analysis Bioinformatics. 24(9): 1214-6
57. 2008 Differentiation between isomeric triantennary N-linked glycans by negative ion tandem mass spectrometry and confirmation of glycans containing galactose attached to the bisecting (beta1-4-GlcNAc) residue in N-glycans from IgG Rapid Commun Mass Spectrom. 22(7): 1047-52
58. 2008 High-throughput screening of glycan-binding proteins using miniature pig kidney N-glycan-immobilized beads Chem Biol. 15(3): 215-23
59. 2008 Monosialylated biantennary N-glycoforms containing GalNAc-GlcNAc antennae predominate when human EPO is expressed in goat milk Arch Biochem Biophys. 470(2): 163-75
60. 2008 The mannose receptor mediates dengue virus infection of macrophages PLoS Pathog. 4(2): e17
61. 2008 Altered glycosylation of proteins in cancer: what is the potential for new anti-tumour strategies Anticancer Agents Med Chem. 8(1): 2-21
62. 2007 Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor J Biol Chem. 282(10): 7405-15
63. 2007 Targeted identification of a unique glycan epitope of Schistosoma mansoni egg antigens using a diagnostic antibody. Mol Biochem Parasitol. 151(2): 148-61
64. 2007 Glycobiology - discovery, diagnostics and drugs Glycobiology, C. Sansom, Markman, O., Editor, Scion Publishing Ltd. 8-11
65. 2007 Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG Glycobiology. 17(12): 1344-56
66. 2007 Changes of serum glycans during sepsis and acute pancreatitis Glycobiology. 17(12): 1321-32
67. 2007 Inhibition of mammalian glycan biosynthesis produces non-self antigens for a broadly neutralising, HIV-1 specific antibody J Mol Biol. 372(1): 16-22
68. 2007 Separation-based glycoprofiling approaches using fluorescent labels Proteomics. 7 Suppl 1: 70-6
69. 2007 The goat mammary glandular epithelial (GMGE) cell line promotes polyfucosylation and N,N'-diacetyllactosediaminylation of N-glycans linked to recombinant human erythropoietin Arch Biochem Biophys. 464(2): 322-34
70. 2007 Folding of an MHC class II-restricted tumor antigen controls its antigenicity via MHC-guided processing Proc Natl Acad Sci U S A. 104(14): 5983-8
71. 2007 Glycosylation changes on serum glycoproteins in ovarian cancer may contribute to disease pathogenesis Dis Markers. 25(4-5): 219-32
72. 2007 Glycosylation of serum ribonuclease 1 indicates a major endothelial origin and reveals an increase in core fucosylation in pancreatic cancer Glycobiology. 17(4): 388-400
73. 2007 Comparison of the methods for profiling glycoprotein glycans--HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study Glycobiology. 17(4): 411-22
74. 2006 Detailed structural analysis of N-glycans released from glycoproteins in SDS-PAGE gel bands using HPLC combined with exoglycosidase array digestions Methods Mol Biol, 347, 125-143.
75. 2006 The identification and characterization of xenoantigenic nonhuman carbohydrate sequences in membrane proteins from porcine kidney Proteomics, 6, 1133-1142
76. 2006 Crystal structure of the TCR co-receptor CD8alphaalpha in complex with monoclonal antibody YTS 105.18 Fab fragment at 2.88 A resolution J Mol Biol, 358, 347-354
77. 2006 Interaction of mannan binding lectin with alpha2 macroglobulin via exposed oligomannose glycans: a conserved feature of the thiol ester protein family? J Biol Chem, 281, 6955-6963
78. 2006 Remnant epitopes, autoimmunity and glycosylation Biochim Biophys Acta, 1760, 610-615
79. 2006 Variable region heavy chain glycosylation determines the anticoagulant activity of a factor VIII antibody J Thromb Haemost, 4, 1047-1055
80. 2006 Sialylation of urinary prothrombin fragment 1 is implicated as a contributory factor in the risk of calcium oxalate kidney stone formation Febs J, 273, 3024-3037
81. 2006 Direct deprotected glycosyl-asparagine ligation Chem Commun (Camb), 1401-1403
82. 2006 Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA Glycobiology, 16, 132-145
83. 2006 The hemopexin and O-glycosylated domains tune gelatinase B/MMP-9 bioavailability via inhibition and binding to cargo receptors J Biol Chem, 281, 18626-18637.
84. 2006 Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy J Am Soc Nephrol, 17, 3529-3539
85. 2006 Human complement factor I glycosylation: structural and functional characterisation of the N-linked oligosaccharides Biochim Biophys Acta, 1764, 1757-1766
86. 2006 Cancer-Associated Glycoforms of Gelatinase B Exhibit a Decreased Level of Binding to Galectin-3 Biochemistry, 45, 15249-15258 10
87. 2006 Mannan binding lectin and its interaction with immunoglobulins in health and in disease Immunol Lett, 106, 103-110
88. 2006 Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans Arthritis Rheum, 54, 3433-3440
89. 2006 Glycobiology and medicine The Biochemist, 28, 18-21
90. 2006 Abnormal glycosylation with hypersialylated O-glycans in patients with Sialuria Biochim Biophys Acta, 1762, 598-607
91. 2006 Inhibition of hybrid- and complex-type glycosylation reveals the presence of the GlcNAc transferase I-independent fucosylation pathway Glycobiology, 16, 748-756
92. 2006 Oligosaccharides modulate the apoptotic activity of glycodelin Glycobiology, 16, 1052-1063.
93. 2006 Analytical strategies to investigate plant N-glycan profiles in the context of plant-made pharmaceuticals Curr Opin Struct Biol, 16, 576-583
94. 2006 Editorial overview - Structural glycobiology in medicine: Carbohydrates and glycoconjuates. Current opinion in structural biology, 16, 559-560
95. 2005 Human immunoglobulin glycosylation and the lectin pathway of complement activation Adv Exp Med Biol, 564, 27-43
96. 2005 Differential glycosylation of gelatinase B from neutrophils and breast cancer cells Adv Exp Med Biol, 564, 103-112
97. 2005 Immunogenicity of calreticulin-bound murine leukemia virus glycoprotein gp90 Adv Exp Med Biol, 564, 85-94
98. 2005 Glycosylation and the function of the T cell co-receptor CD8 Adv Exp Med Biol, 564, 71-84
99. 2005 Glycosylation influences the ligand binding activities of mannose receptor. Adv Exp Med Biol, 564, 25-26
100. 2005 Antibody recognition of a carbohydrate epitope: a template for HIV vaccine design Adv Exp Med Biol, 564, 7-8
101. 2005 Glycosylation: disease targets and therapy. Adv Exp Med Biol, 564, 1-2
102. 2005 Glycosylation influences the lectin activities of the macrophage mannose receptor J Biol Chem, 280, 32811-32820
103. 2005 Human serum IgM glycosylation: identification of glycoforms that can bind to mannan-binding lectin J Biol Chem, 280, 29080-29087
104. 2005 Molecular mechanism of lipopeptide presentation by CD1a Immunity, 22, 209-219
105. 2005 Afamin is a novel human vitamin E-binding glycoprotein characterization and in vitro expression J Proteome Res, 4, 889-899
106. 2005 Epitope recognition of antibodies that define the sialomucin, endolyn (CD164), a negative regulator of haematopoiesis. Tissue Antigens, 65, 220-239. 8
107. 2004 Inhibition of alpha-glucosidases I and II increases the cell surface expression of functional class A macrophage scavenger receptor (SR-A) by extending its half-life J Biol Chem, 279, 39303-39309
108. 2004 Identification and removal of O-linked and non-covalently linked sugars from recombinant protein produced using Pichia pastoris Protein Expr Purif, 38, 217-227
109. 2004 Complement regulation at the molecular level: the structure of decay-accelerating factor Proc Natl Acad Sci U S A, 101, 1279-1284. 7
110. 2004 Sugar-mediated ligand-receptor interactions in the immune system Trends Biotechnol, 22, 524-530
111. 2004 Artefacts formed by addition of urea to N-linked glycans released with peptide-N-glycosidase F for analysis by mass spectrometry. Rapid Commun Mass Spectrom, 18, 2357-2359
112. 2004 Structural characterization of the N-glycan moiety and site of glycosylation in vitellogenin from the decapod crustacean Cherax quadricarinatus Glycobiology, 14, 767-774
113. 2004 Monoglucosylated glycans in the secreted human complement component C3: implications for protein biosynthesis and structure FEBS Lett, 566, 270-274
114. 2004 Major histocompatibility complex class I molecules expressed with monoglucosylated N-linked glycans bind calreticulin independently of their assembly status J Biol Chem, 279, 25112-25121
115. 2004 Controlled glycosylation of therapeutic antibodies in plants. Arch Biochem Biophys, 426, 266-278.
116. 2004 Reactivity-based one-pot synthesis of oligomannoses: defining antigens recognized by 2G12, a broadly neutralizing anti-HIV-1 antibody. Angew Chem Int Ed Engl, 43, 1000-1003
117. 2004 The glycosylation of human serum IgD and IgE and the accessibility of identified oligomannose structures for interaction with mannan-binding lectin J Immunol, 173, 6831-6840
118. 2003 Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis Glycobiology, 13, 601-622
119. 2003 Crystal structure of an intact human IgG: antibody asymmetry, flexibility, and a guide for HIV-1 vaccine design Adv Exp Med Biol, 535, 55-66
120. 2003 Antibody domain exchange is an immunological solution to carbohydrate cluster recognition Science, 300, 2065-2071
121. 2003 Function and glycosylation of plant-derived antiviral monoclonal antibody Proc Natl Acad Sci U S A, 100, 8013-8018
122. 2003 The carbohydrate epitope of the neutralizing anti-HIV-1 antibody 2G12. Adv Exp Med Biol, 535, 205-218
123. 2003 Secretory IgA N- and O-glycans provide a link between the innate and adaptive immune systems J Biol Chem, 278, 20140-20153
124. 2003 O-glycan sialylation and the structure of the stalk-like region of the T cell co-receptor CD8 J Biol Chem, 278, 27119-27128
125. 2003 Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins Glycobiology, 13, 457-470
126. 2003 Structural determination of the N-glycans of a lepidopteran arylphorin reveals the presence of a monoglucosylated oligosaccharide in the storage protein Glycobiology, 13, 147-157
127. 2003 Glycosylation of human pancreatic ribonuclease: differences between normal and tumor states Glycobiology, 13, 227-244
128. 2002 Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol, 37, 375-536
129. 2002 Monitoring endoplasmic reticulum-to-Golgi traffic of a plant calreticulin by protein glycosylation analysis Biochemistry, 41, 14141-14149
130. 2002 Identification of specific glycoforms of major histocompatibility complex class I heavy chains suggests that class I peptide loading is an adaptation of the quality control pathway involving calreticulin and ERp57. J Biol Chem, 277, 46415-46423
131. 2002 Glycosylation and prion protein Curr Opin Struct Biol, 12, 578-586
132. 2002 The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120 J Virol, 76, 7306-7321
133. 2002 Contrasting IgG structures reveal extreme asymmetry and flexibility J Mol Biol, 319, 9-18
134. 2002 Recovery of intact 2-aminobenzamide-labeled O-glycans released from glycoproteins by hydrazinolysis Anal Biochem, 304, 91-99. 6
135. 2002 Comparison of the N-linked glycans from soluble and GPI-anchored CD59 expressed in CHO cells Glycobiology, 12, 261-271
136. 2002 Glycosylation and the complement system Chem Rev, 102, 305-320-319
137. 2002 "Internal residue loss": rearrangements occurring during the fragmentation of carbohydrates derivatized at the reducing terminus Anal Chem, 74, 734-740
138. 2002 The carbohydrate moiety of serum IgM from Atlantic cod (Gadus morhua L.) Fish Shellfish Immunol, 12, 209-227
139. 2001 Matrix remodelling enzymes, the protease cascade and glycosylation Biochim Biophys Acta, 1528, 61-73
140. 2001 Antibodies inhibit prion propagation and clear cell cultures of prion infectivity Nature, 412, 739-743
141. 2001 Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design Science, 293, 1155-1159
142. 2001 Characterization of human apolipoprotein B100 oligosaccharides in LDL subfractions derived from normal and hyperlipidemic plasma: deficiency of alpha-N-acetylneuraminyllactosyl-ceramide in light and small dense LDL particles Glycobiology, 11, 791-802.
143. 2001 Holistic approaches to glycobiology Nat Biotechnol, 19, 531-532
144. 2001 Structural elucidation of the N- and O-glycans of human apolipoprotein(a): role of o-glycans in conferring protease resistan J Biol Chem, 276, 22200-22208
145. 2001 Glycosylation and the immune system Science, 291, 2370-2376
146. 2001 Prion glycoprotein: structure, dynamics, and roles for the sugars Biochemistry, 40, 3759-3766
147. 2001 A high-performance liquid chromatography based strategy for rapid, sensitive sequencing of N-linked oligosaccharide modifications to proteins in sodium dodecyl sulphate polyacrylamide electrophoresis gel bands Proteomics, 1, 285-294.
148. 2000 Two edged role of mannose binding lectin in rheumatoid arthritis: a cross sectional study. J Rheumatol, 27, 26-34.
149. 2000 O-glycan analysis of natural human neutrophil gelatinase B using a combination of normal phase-HPLC and online tandem mass spectrometry: implications for the domain organization of the enzyme Biochemistry, 39, 15695-15704
150. 2000 Influence of baculovirus-host cell interactions on complex N-linked glycosylation of a recombinant human protein Biotechnol Prog, 16, 650-656
151. 2000 Protein structure controls the processing of the N-linked oligosaccharides and glycosylphosphatidylinositol glycans of variant surface glycoproteins expressed in bloodstream form Trypanosoma brucei Glycobiology, 10, 243-249
152. 2000 Hybrid and complex glycans are linked to the conserved N-glycosylation site of the third eight-cysteine domain of LTBP-1 in insect cells. Biochemistry, 39, 1596-1603
153. 1999 The glycan processing and site occupancy of recombinant Thy-1 is markedly affected by the presence of a glycosylphosphatidylinositol anchor. Glycobiology, 9, 1381-1387
154. 1999 Cell-specific glycoforms of sialoadhesin and CD45 are counter-receptors for the cysteine-rich domain of the mannose receptor J Biol Chem, 274, 35211-35218
155. 1999 Glycosylation differences between the normal and pathogenic prion protein isoforms Proc Natl Acad Sci U S A, 96, 13044-13049
156. 1999 Roles for glycosylation of cell surface receptors involved in cellular immune recognition J Mol Biol, 293, 351-366
157. 1999 Glycosylation of natural human neutrophil gelatinase B and neutrophil gelatinase B-associated lipocalin Biochemistry, 38, 13937-13950
158. 1999 Sugar printing rheumatic diseases: a potential method for disease differentiation using immunoglobulin G oligosaccharides Arthritis Rheum, 42, 1682-1690
159. 1999 Oligosaccharide analysis and molecular modeling of soluble forms of glycoproteins belonging to the Ly-6, scavenger receptor, and immunoglobulin superfamilies expressed in Chinese hamster ovary cells Glycobiology, 9, 443-458
160. 1999 Glycoproteins: rapid sequencing technology for N-linked and GPI anchor glycans ) Biotechnol Genet Eng Rev, 16, 1-21
161. 1998 Glycosylation and the immune system J Protein Chem, 17, 519
162. 1998 Oligosaccharides of recombinant mouse gelatinase B variants Biochim Biophys Acta, 1425, 587-598
163. 1998 Structural analysis of the CD5 antigen--expression, disulphide bond analysis and physical characterisation of CD5 scavenger receptor superfamily domain 1 Eur J Biochem, 257, 131-141. 4
164. 1998 Alpha-glucosidase inhibitors as potential broad based anti-viral agents ) FEBS Lett, 430, 17-22
165. 1998 Concepts and principles of O-linked glycosylation Crit Rev Biochem Mol Biol, 33, 151-208.
166. 1998 Quantitation of the oligosaccharides of human serum IgG from patients with rheumatoid arthritis: a critical evaluation of different methods. J Immunol Methods, 213, 113-130
167. 1998 Mutant analysis reveals an alternative pathway for N-linked glycosylation in Drosophila melanogaster Eur J Biochem, 253, 494-498
168. 1998 Genomic cloning and expression of three murine UDP-galactose: beta-N-acetylglucosamine beta1,3-galactosyltransferase genes J Biol Chem, 273, 58-65
169. 1998 The glycosylation of the complement regulatory protein, human erythrocyte CD59. Adv Exp Med Biol, 435, 153-162.
170. 1998 The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fc alpha receptor interactions J Biol Chem, 273, 2260-2272.
171. 1997 Roles for glycosylation in the anti-inflammatory molecule CD59 Biochem Soc Trans, 25, 1177-1184
172. 1997 A strategy for anti-viral intervention: the use of alpha-glucosidase inhibitors to prevent chaperone-mediated folding of viral envelope glycoproteins Biochem Soc Trans, 25, 1188-1193
173. 1997 Oligosaccharide sequencing technology Nature, 388, 205-207
174. 1997 Rapid, sensitive sequencing of oligosaccharides from glycoproteins. Curr Opin Biotechnol, 8, 488-497.
175. 1997 Glycosylation: heterogeneity and the 3D structure of proteins Crit Rev Biochem Mol Biol, 32, 1-100
176. 1997 Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides Biochemistry, 36, 1370-1380
177. 1997 The glycosylation of the complement regulatory protein, human erythrocyte CD59. J Biol Chem, 272, 7229-7244
178. 1997 Conformation-independent binding of monoglucosylated ribonuclease B to calnexin Cell, 88, 29-38
179. 1996 A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles. Anal Biochem, 240, 210-226. 3
180. 1996 The identification of abnormal glycoforms of serum transferrin in carbohydrate deficient glycoprotein syndrome type I by capillary zone electrophoresis Glycoconj J, 13, 1031-1042
181. 1995 Lectin-carbohydrate interactions in disease. T-cell recognition of IgA and IgD; mannose binding protein recognition of IgG0 Adv Exp Med Biol, 376, 147-152
182. 1995 Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein Nat Med, 1, 237-243
183. 1995 Cells regulate the activities of cytokines by glycosylation. Faseb J, 9, 453-457.
184. 1995 The activation of type 1 and type 2 plasminogen by type I and type II tissue plasminogen activator J Biol Chem, 270, 3261-3267
185. 1995 The effects of variable glycosylation on the functional activities of ribonuclease, plasminogen and tissue plasminogen activator Biochim Biophys Acta, 1248, 1-10
186. 1994 A human T-cell receptor recognizes 'O'-linked sugars from the hinge region of human IgA1 and IgD Immunology, 83, 99-106
187. 1994 Glycoforms modify the dynamic stability and functional activity of an enzyme Biochemistry, 33, 17-22
188. 1994 Structural analysis of the N-glycans from human immunoglobulin A1: comparison of normal human serum immunoglobulin A1 with that isolated from patients with rheumatoid arthritis Biochem J, 299 ( Pt 1), 261-275
189. 1993 Applications of electrospray mass spectrometrometry studies to studies on the structural properties of Ribonuclease A and ribonuclease B 7 332-335
190. 1993 Concepts and principles of glycobiology Faseb J, 7, 1330-1337
191. 1992 Separation and analysis of the glycoform populations of ribonuclease B using capillary electrophoresis. Glycoconj J, 9, 86-91.
192. 1991 Diversification of the IgG molecule by oligosaccharides Mol Immunol, 28, 1369-1378
193. 1989 N-glycosylation and in vitro enzymatic activity of human recombinant tissue plasminogen activator expressed in Chinese hamster ovary cells and a murine cell line Biochemistry, 28, 7670-7679
194. 1989 Effects of N-glycosylation on in vitro activity of Bowes melanoma and human colon fibroblast derived tissue plasminogen activator Biochemistry, 28, 7662-7669


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.